StreetInsider.com News Articles

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: FENTON DENNIS M

Fri, 12 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260612/26640838.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: FENTON DENNIS M

Fri, 12 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260612/26640838.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Jain Rita

Fri, 12 Jun 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260612/26640814.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Jain Rita

Fri, 12 Jun 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260612/26640814.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Orwin John A

Fri, 12 Jun 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260612/26640785.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Orwin John A

Fri, 12 Jun 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260612/26640785.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Marquet Magda

Fri, 12 Jun 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260612/26640800.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Marquet Magda

Fri, 12 Jun 2026 16:08:00 -0400

si-local-file:///var/storage/secattach/20260612/26640800.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Schmid John P.

Fri, 12 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260612/26640757.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Schmid John P.

Fri, 12 Jun 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260612/26640757.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Ware J. Anthony

Fri, 12 Jun 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260612/26640533.html

Form 4/A First Tracks Biotherapeu For: May 12 Filed by: Ware J. Anthony

Fri, 12 Jun 2026 16:02:00 -0400

si-local-file:///var/storage/secattach/20260612/26640533.html

Wells Fargo Starts First Tracks Biotherapeutics (TRAX) at Overweight

Mon, 08 Jun 2026 05:00:28 -0400

Wells Fargo initiates coverage on First Tracks Biotherapeutics (NASDAQ: TRAX) with a Overweight rating and a price target of $30.00.

For an analyst ratings summary and ratings history on First Tracks Biotherapeutics click here. For more ratings news on First Tracks Biotherapeutics click here.

Shares of First Tracks Biotherapeutics closed at $16.60 yesterday.

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences

Thu, 21 May 2026 16:15:00 -0400

SAN DIEGO, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today announced that Daniel Faga, president and chief executive officer, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences:

2026 Jefferies Global Healthcare Conference, New York

Format – Presentation and one-on-one investor meetings
Date and Time – Wednesday, June 3, 2026 at 12:15pm ET / 9:15am PT

Leerink Partners Therapeutics Forum, Boston

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences

Thu, 21 May 2026 16:15:00 -0400

2026 Jefferies Global Healthcare Conference, New York

Format – Presentation and one-on-one investor meetings
Date and Time – Wednesday, June 3, 2026 at 12:15pm ET / 9:15am PT

Leerink Partners Therapeutics Forum, Boston

Form 424B3 First Tracks Biotherapeu

Fri, 15 May 2026 16:12:00 -0400

si-local-file:///var/storage/secattach/20260515/26505253.html

Form 424B3 First Tracks Biotherapeu

Thu, 14 May 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260514/26496597.html

Form 10-Q First Tracks Biotherapeu For: Mar 31

Thu, 14 May 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260514/26495805.html

Form 8-K First Tracks Biotherapeu For: May 14

Thu, 14 May 2026 16:25:00 -0400

si-local-file:///var/storage/secattach/20260514/26495507.html

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Thu, 14 May 2026 16:15:00 -0400

First Tracks launched April 20^th with a two-year cash-runway to advance ANB033 through celiac disease and eosinophilic esophagitis Phase 1b data and plans to initiate Phase 2 trials across four indications

SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today reported financial results for the first quarter ended March 31, 2026, and provided a business update.

“First Tracks Bio launched to advance a focused, high-value immunology portfolio that can create meaningful

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

Thu, 14 May 2026 16:15:00 -0400

First Tracks launched April 20^th with a two-year cash-runway to advance ANB033 through celiac disease and eosinophilic esophagitis Phase 1b data and plans to initiate Phase 2 trials across four indications

“First Tracks Bio launched to advance a focused, high-value immunology portfolio that can create meaningful

Form 4 First Tracks Biotherapeu For: May 12 Filed by: STONE BENJAMIN

Thu, 14 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260514/26494643.html

Form 4 First Tracks Biotherapeu For: May 12 Filed by: STONE BENJAMIN

Thu, 14 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260514/26494643.html

Form 4 First Tracks Biotherapeu For: May 12 Filed by: FENTON DENNIS M

Thu, 14 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260514/26494645.html

Form 4 First Tracks Biotherapeu For: May 12 Filed by: FENTON DENNIS M

Thu, 14 May 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260514/26494645.html